Orthofix Medical Inc. (OFIX)

Orthofix Medical Inc.'s Q·Score is 6.1/10 (Neutral), reflecting its current fundamentals, analyst data, and valuation metrics. Consensus analyst target of $15.00 is 55% above current price. Key area to monitor: currently unprofitable (-7% margin). This is an informational data summary only and does not constitute financial advice. Always do your own research before making any investment decision.

The consensus price target for OFIX is $15.00, based on ratings from 4 Wall Street analysts. This is 55.1% above the current price of $9.67. Price targets are forward-looking estimates and not guarantees of future performance.

Orthofix Medical Inc. (OFIX) scores favorably on valuation metrics relative to sector peers and analyst targets. Its forward P/E ratio stands at 13.6×. The consensus analyst price target of $15.00 is 55% above the current price.

Orthofix Medical Inc.'s next earnings report is expected on approximately August 4, 2026.

Orthofix Medical Inc. has a net profit margin of -7.3%, indicating the company is currently operating at a net loss. Its gross margin stands at 71.0%, indicating a high-margin business model.

Orthofix Medical Inc. is reporting modest revenue growth of 1.6%.

Orthofix Medical Inc. has a debt-to-equity ratio of 0.60×, reflecting a moderate debt level, which is manageable for most profitable companies. Its current ratio is 2.87×, indicating comfortable short-term liquidity.